VANCOUVER, BC / ACCESS Newswire / December 18, 2025 / Sun Peak Metals Corp. (TSXV:PEAK)(OTCQB:SUNPF) ("Sun Peak" or the "Company") is pleased to announce the successful completion of its previously an ...
Achieves another quarter of higher-than-expected revenue and profitability and hits the top-end of cash flow guidanceQNX division achieves highest revenue quarter everSecure Communications division be ...
MINNEAPOLIS, MN / ACCESS Newswire / December 18, 2025 / Air T, Inc. (NASDAQ:AIRT) is pleased to announce the successful closing of its acquisition of Regional Express Holdings Limited (Rex), Australia ...
MURFREESBORO, TN / ACCESS Newswire / December 18, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today that it has invested $89.2 million, including transaction costs, in four separate tr ...
SUNNYVALE, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- eGain Corporation (NASDAQ: EGAN), the leading AI knowledge platform for customer experience, today announced that Achmea, one of Europe's largest c ...
MEMPHIS (dpa-AFX) - In einem schwachen Wirtschaftsumfeld hat der US-Logistikkonzern Fedex mit seinem Kostenfokus überzeugen können. Im zweiten Geschäftsquartal (Ende November) verdiente der DHL-Konkur ...
Air Lease (NYSE: AL) announced today that its Class A common stockholders have voted to approve the previously announced definitive merger agreement, dated as of September 1, 2025, pursuant to which ...
Bringt's der E-Polo? Der VW-Konzern tritt auf die Kostenbremse, setzt aber auf eigene Batteriefertigung is Salzgitter! Volkswagen Vz. (VOW3) - ISIN DE0005158703 Rückblick: Die These, dass das gekippte ...
Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in diagnostic and prognostic innovation through advanced ...
WOBURN, MASSACHUSETTS / ACCESS Newswire / December 18, 2025 / Bridgeline Digital, Inc. (NASDAQ:BLIN), a leader in AI-powered marketing technology, today announced financial results for its fiscal 2025 ...
Die strategische Entscheidung von Rheinmetall, sich auf den Defence-Bereich zu fokussieren, sorgt am Markt weiter für Diskussionen. Vor allem die neue Prognose gilt bei manchen Beobachtern als Überras ...
6h
Curasight Announces Successful Dosing of First Patient in Phase 1 trial with uTREAT in Brain Cancer
Phase 1 trial in aggressive brain cancer (Glioblastoma) is the first clinical trial of uTREAT belonging to Curasight's treatment platformNo patient safety issues were reported The dosing marks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback